Mdr1 limits CYP3A metabolism in vivo

Molecular Pharmacology

Volumn 58, Issue 4, 2000, Pages 863-869

  Lan, Lu Bin ^a   Dalton, James T ^b   Schuetz, Erin G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBON 14; CARBON DIOXIDE; CYTOCHROME P450; DEXAMETHASONE; ERYTHROMYCIN; ERYTHROMYCIN N DEMETHYLASE; GLYCOPROTEIN P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DEMETHYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SUBSTRATE; LIVER METABOLISM; LIVER MICROSOME; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033798115     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.4.863     Document Type: Article

References (31)

1. Intersubject and dose-related variability after intravenous administration of erythromycin
2. Creation of polarized cells co-expressing CYP3A4. NADPH cytochrome P450 reductase and MDR1/P-glycoprotein
3. CYP3A-like cytochrome P-450 mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells
4. Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activities
5. Immunologic comparison of extrahepatic cytochromes P-450
6. Metabolism of taxol by human hepatic microsomes and liver slices: Participation of cytochrome P4503A4 and an unknown P450 enzyme
7. Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-4503A4
8. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
9. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
10. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A
11. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein
12. Unchanged cytochrome P450 3A (CYP3A) Expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes
13. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers
14. 14C]-erythromycin
15. Modulation of P-glycoprotein expression by cytochrome P4503A inducers in male and female rat livers
16. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A
17. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms
18. P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans
19. Altered expression of hepatic cytochromes P450 in mice deficient in one or more mdr1 genes
20. Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene
21. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver
22. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
23. Altered pharmacokinetics of vinblastine in mdr1a P-g]ycoprotein-deficient mice
24. Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
25. The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver
26. Breath tests as noninvasive assays of P450s
27. Noninvasive tests of CYP3A enymes
28. The erythromycin breath test as a predictor of cyclosporine blood levels
29. Identification of an inducible form of cytochrome P-450 in human liver
30. The human drug metabolizing cytochromes P450
31. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450